WuXi Biologics - Operating Income

WuXi Biologics's Fiscal Year is From January To December - All Figures are in CNY, Billions.

The item "Operating-Income" stands at 5.88 Billion Chinese Yuans for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 03/31/2015, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 69.62 percent compared to the value the year prior.
The 1 year change in percent is 69.62.
The 3 year change in percent is 46.45.
The 5 year change in percent is 538.01.
The 10 year change in percent is 7,374.25.

The Serie's long term average value is 1.91 Billion Chinese Yuans. It's latest available value, on 06/30/2025, is 207.05 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2014, to it's latest available value, on 06/30/2025, is +8,516.08%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.